1. Home
  2. BURL vs UTHR Comparison

BURL vs UTHR Comparison

Compare BURL & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BURL

Burlington Stores Inc.

HOLD

Current Price

$295.31

Market Cap

18.2B

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$468.08

Market Cap

21.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BURL
UTHR
Founded
1972
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2B
21.4B
IPO Year
2013
1999

Fundamental Metrics

Financial Performance
Metric
BURL
UTHR
Price
$295.31
$468.08
Analyst Decision
Strong Buy
Buy
Analyst Count
16
12
Target Price
$336.57
$498.83
AVG Volume (30 Days)
831.4K
353.5K
Earning Date
03-05-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
19.59
16.08
EPS
8.72
26.38
Revenue
$11,187,977,000.00
$3,128,400,000.00
Revenue This Year
$10.25
$13.57
Revenue Next Year
$9.27
$5.72
P/E Ratio
$33.94
$17.80
Revenue Growth
6.81
13.50
52 Week Low
$212.92
$266.98
52 Week High
$315.14
$519.99

Technical Indicators

Market Signals
Indicator
BURL
UTHR
Relative Strength Index (RSI) 52.21 41.68
Support Level $286.74 $464.16
Resistance Level $295.78 $479.41
Average True Range (ATR) 8.23 9.39
MACD -2.52 -0.98
Stochastic Oscillator 36.65 43.74

Price Performance

Historical Comparison
BURL
UTHR

About BURL Burlington Stores Inc.

Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: